Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Gv20 Therapeutics

Clinical trials sponsored by Gv20 Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New hope for Hard-to-Treat cancers: experimental drug enters human trials Results expected Jul 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1 Not yet recruiting 1
Sort by
  • New hope for hard-to-treat cancers? experimental combo enters phase 2 trial

    Disease control Not yet recruiting

    This study tests a new drug (GV20-0251) combined with an immunotherapy (anti-PD-1) in people with advanced solid tumors that have not responded to or cannot tolerate standard treatments. About 227 adults with various cancers, including lung, breast, and colorectal, will participa…

    Phase 2 • Sponsor: GV20 Therapeutics • Aim: Disease control

    Last updated Jun 27, 2026 13:04 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space